Trial Profile
Open-label, single dose crossover, relative bioavailability study comparing 10 microg vaginal estradiol formulations TX 12004HR and Vagifem
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Apr 2015
Price :
$35
*
At a glance
- Drugs Estradiol (Primary)
- Indications Atrophic vaginitis
- Focus Pharmacokinetics
- 11 Feb 2014 New trial record
- 28 Jan 2014 Final results published in a TherapeuticsMD media release.